TG Therapeutics: Q3 Earnings Snapshot
By AP News
Published - Nov 04, 2024, 07:06 AM ET
Last Updated - Dec 16, 2024, 05:43 PM EST
MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported third-quarter earnings of $3.9 million.
On a per-share basis, the Morrisville, New York-based company said it had profit of 2 cents.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.
The biopharmaceutical company posted revenue of $83.9 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $80.3 million.
